131I-Metaiodobenzylguanidine conditioning regimen in children with neuroblastoma undergoing stem cell transplantation

Saved in:

Bibliographic Details
Published in:	Pediatric transplantation Vol. 17; no. 4; pp. 407 - 408
Main Authors:	Atas, Erman, Kesik, Vural, Kismet, Erol, Koseoglu, Vedat
Format:	Journal Article
Language:	English
Published:	Denmark Blackwell Publishing Ltd 01-06-2013
Subjects:	3-Iodobenzylguanidine - adverse effects 3-Iodobenzylguanidine - therapeutic use Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Bone Marrow Transplantation Child Fatal Outcome Female Humans Infant Iodine Radioisotopes - adverse effects Iodine Radioisotopes - therapeutic use Mucositis - chemically induced Neuroblastoma - therapy Stem Cell Transplantation Transplantation Conditioning - methods
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Author	Atas, Erman Kismet, Erol Kesik, Vural Koseoglu, Vedat
Author_xml	– sequence: 1 givenname: Erman surname: Atas fullname: Atas, Erman organization: Pediatric Oncology, Gulhane Military Medical Academy, Ankara, Turkey – sequence: 2 givenname: Vural surname: Kesik fullname: Kesik, Vural organization: Pediatric Oncology, Gulhane Military Medical Academy, Ankara, Turkey – sequence: 3 givenname: Erol surname: Kismet fullname: Kismet, Erol organization: Pediatric Oncology, Gulhane Military Medical Academy, Ankara, Turkey – sequence: 4 givenname: Vedat surname: Koseoglu fullname: Koseoglu, Vedat email: eatasdr@gmail.com organization: Pediatric Oncology, Gulhane Military Medical Academy, Ankara, Turkey
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/23692603$$D View this record in MEDLINE/PubMed
BookMark	eNp9kF1PwjAUhhujkQ-98QeYXZsM23Ws26UhiBhUoqiJN03XHqC6tUu3BfHXO0C49Nycc_G8b3KeDjo21gBCFwT3SDPXBVSuRwIcsyPUJjRJfIrD6Hh7M5-SMGihTll-YkyiMA5PUSugURJEmLZRTSgZ-w9QCW2VTcH8rLNFLYxW2oAnrVG60tZos_AcLHQOxtPGk0udKdfcK10tPQO1s2kmysrmwquNArewm0RZQe5JyDKvcsKURSZMJTZ1Z-hkLrISzv92F73eDmeDO3_yNBoPbia-DBLKfNl8J-cikThlscSsjxOq5oqFQcSAEQapIDgFloYJhSjGDUvjJCZNOJBBrGgXXe16pbNl6WDOC6dz4dacYL5xxzfu-NZdA1_u4KJOc1AHdC-rAcgOWOkM1v9U8elw9rwv9XcZ3cj4PmSE--IRo6zP3x9H_OXt4346nUac0F_36o3w
Cites_doi	10.1053/j.semnuclmed.2011.06.001 10.1200/JCO.2002.08.124 10.1200/JCO.2005.03.6400 10.2298/AOO0602045M 10.1093/annonc/mdm111 10.1016/S0959-8049(98)00130-0
ContentType	Journal Article
Copyright	2013 John Wiley & Sons A/S.
Copyright_xml	– notice: 2013 John Wiley & Sons A/S.
DBID	BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION
DOI	10.1111/petr.12087
DatabaseName	Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef
Database_xml	– sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1399-3046
EndPage	408
ExternalDocumentID	10_1111_petr_12087 23692603 PETR12087 ark_67375_WNG_SVZJPPP6_1
Genre	letter Letter Case Reports
GroupedDBID	--- .3N .GA .Y3 05W 0R~ 10A 123 1OC 29O 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K ROL RX1 SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAMNL AAYXX CITATION
ID	FETCH-LOGICAL-c2937-c111cfa9c0b78c075093dfd74267e717eba10be7b493e680cfa389812932c28d3
IEDL.DBID	33P
ISSN	1397-3142
IngestDate	Thu Nov 21 23:33:21 EST 2024 Sat Sep 28 08:08:36 EDT 2024 Sat Aug 24 00:58:04 EDT 2024 Wed Oct 30 09:49:06 EDT 2024
IsPeerReviewed	true
IsScholarly	true
Issue	4
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c2937-c111cfa9c0b78c075093dfd74267e717eba10be7b493e680cfa389812932c28d3
Notes	istex:1E4A2BECB99206B67F02FCEDD6FFB3DA8EB8F5FA ArticleID:PETR12087 ark:/67375/WNG-SVZJPPP6-1
PMID	23692603
PageCount	2
ParticipantIDs	crossref_primary_10_1111_petr_12087 pubmed_primary_23692603 wiley_primary_10_1111_petr_12087_PETR12087 istex_primary_ark_67375_WNG_SVZJPPP6_1
PublicationCentury	2000
PublicationDate	2013-06 June 2013 2013-Jun 2013-06-00
PublicationDateYYYYMMDD	2013-06-01
PublicationDate_xml	– month: 06 year: 2013 text: 2013-06
PublicationDecade	2010
PublicationPlace	Denmark
PublicationPlace_xml	– name: Denmark
PublicationTitle	Pediatric transplantation
PublicationTitleAlternate	Pediatr Transplantation
PublicationYear	2013
Publisher	Blackwell Publishing Ltd
Publisher_xml	– name: Blackwell Publishing Ltd
References	Mihailović J. Current concepts of 131I therapy in oncology: Indications, methods and follow up. Arch Oncol 2006: 14: 45-51. Klingebiel T, Bader P, Bares R, et al. Treatment of neuroblastoma stage 4 with 131I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study. Eur J Cancer 1998: 34: 1398-1402. Oyen WJ, Bodei L, Giammarile F, et al. Targeted therapy in nuclear medicine-current status and future prospects. Ann Oncol 2007: 18: 1782-1792. Shusterman S, Grant FD, Lorenzen W, et al. Iodine-131-labeled meta-iodobenzylguanidine therapy of children with neuroblastoma: Program planning and initial experience. Semin Nucl Med 2011: 41: 354-363. Yanik GA, Levine JE, Matthay KK, et al. Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma. J Clin Oncol 2002: 20: 2142-2149. Harbert JC. Nuclear Medicine Therapy. New York: Thieme Medical Publishers, Inc, 1987, pp. 98-108. Matthay KK, Tan JC, Villablanca JG, et al. Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: A new approaches to Neuroblastoma Therapy Consortium Study. J Clin Oncol 2006: 24: 500-506. 1987 2007; 18 2011; 41 2002; 20 2006; 24 1998; 34 2006; 14 e_1_2_2_4_1 e_1_2_2_5_1 e_1_2_2_7_1 Harbert JC (e_1_2_2_6_1) 1987 e_1_2_2_2_1 e_1_2_2_3_1 e_1_2_2_8_1
References_xml	– volume: 20 start-page: 2142 year: 2002 end-page: 2149 article-title: Pilot study of iodine‐131‐metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem‐cell support for the treatment of neuroblastoma publication-title: J Clin Oncol – start-page: 98 year: 1987 end-page: 108 – volume: 34 start-page: 1398 year: 1998 end-page: 1402 article-title: Treatment of neuroblastoma stage 4 with 131I‐meta‐iodo‐benzylguanidine, high‐dose chemotherapy and immunotherapy. A pilot study publication-title: Eur J Cancer – volume: 14 start-page: 45 year: 2006 end-page: 51 article-title: Current concepts of 131I therapy in oncology: Indications, methods and follow up publication-title: Arch Oncol – volume: 18 start-page: 1782 year: 2007 end-page: 1792 article-title: Targeted therapy in nuclear medicine–current status and future prospects publication-title: Ann Oncol – volume: 24 start-page: 500 year: 2006 end-page: 506 article-title: Phase I dose escalation of iodine‐131‐metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem‐cell transplantation in refractory neuroblastoma: A new approaches to Neuroblastoma Therapy Consortium Study publication-title: J Clin Oncol – volume: 41 start-page: 354 year: 2011 end-page: 363 article-title: Iodine‐131‐labeled meta‐iodobenzylguanidine therapy of children with neuroblastoma: Program planning and initial experience publication-title: Semin Nucl Med – ident: e_1_2_2_5_1 doi: 10.1053/j.semnuclmed.2011.06.001 – ident: e_1_2_2_3_1 doi: 10.1200/JCO.2002.08.124 – ident: e_1_2_2_4_1 doi: 10.1200/JCO.2005.03.6400 – start-page: 98 volume-title: Nuclear Medicine Therapy year: 1987 ident: e_1_2_2_6_1 contributor: fullname: Harbert JC – ident: e_1_2_2_7_1 doi: 10.2298/AOO0602045M – ident: e_1_2_2_2_1 doi: 10.1093/annonc/mdm111 – ident: e_1_2_2_8_1 doi: 10.1016/S0959-8049(98)00130-0
SSID	ssj0016484
Score	2.0289614
SourceID	crossref pubmed wiley istex
SourceType	Aggregation Database Index Database Publisher
StartPage	407
SubjectTerms	3-Iodobenzylguanidine - adverse effects 3-Iodobenzylguanidine - therapeutic use Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Bone Marrow Transplantation Child Fatal Outcome Female Humans Infant Iodine Radioisotopes - adverse effects Iodine Radioisotopes - therapeutic use Mucositis - chemically induced Neuroblastoma - therapy Stem Cell Transplantation Transplantation Conditioning - methods
Title	131I-Metaiodobenzylguanidine conditioning regimen in children with neuroblastoma undergoing stem cell transplantation
URI	https://api.istex.fr/ark:/67375/WNG-SVZJPPP6-1/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fpetr.12087 https://www.ncbi.nlm.nih.gov/pubmed/23692603
Volume	17
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA66gnjx_VhfBBQPQiVpu2kDXkTXFyjFN15Kk6bLonZl3cXHyZ_gb_SXOJN21_UiiLceJrTNZDLfN8nMELLOZZBqNCSjFXP8wBVOojIAcqImYcvkgJmRKB6eB6c34V4dy-Rs93JhivoQ_YAbWobdr9HAE_U0YOQAKttb3GUhppIDTbD5G17UP0IQflh0tJUYiPPdsjYpXuP5HvrDG43gxL4MuKJBuGr9zf7E_750koyXOJPuFAtjigyZfJqMnpQn6TPkmXv86PP94wSvkAI1VSZ_e71vdJO8Cd7MUKDJabMM1lLs3vBgctrMaS_5m2IAl9pqmAoAeKf1kFDMR2s3WjgCy0NTPBSgHVs9_T4pUpzyWXK5X7_YPXTKJgyOBiQQOBr-QWeJ1EwFobYAw0uzFBi1CAxwQaMSzpQJlC89I0IGsoCBQoQRrnbD1JsjlbyVmwVCZcZEqpVkvkrBDWbKCK5hP4GJ0ZLJsErWesqIH4taG3GPo-AcxnYOq2TD6qkvkrTv8HZaUIuvTw_i86vb4yiKRMyrZL5QZF_S9YQE_uZVyabV1y9viaP6xZl9WvyL8BIZc4t-GQ7jy6TSaXfNChl-SrurdnV-AaeW6KU
link.rule.ids	315,782,786,1408,27933,27934,46064,46488
linkProvider	Wiley-Blackwell
linkToHtml	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1RT9RAEJ4IJOoLiooeImyi8cGkZLctu90HHogeHMpdGjnB-NJ0t1tyEXrkuIvikz-B3-gvYWbbO84XEuNb08xm25mdnW9md2YA3gitCkuK5KzhQaxCGeSmRCAntzVumQIxMzmKnSPV-5p8aFOZnJ1pLkxdH2IWcCPN8Ps1KTgFpOe0HFHlaEuEPFELsBRLXImUwRGls0MEfFX3tNUUiovDpjopXeS5HfuXPVoi1v6cM0bzgNVbnL1H__mtj2G5gZpst14bK3DPVU_gfrc5TH8KP0QkDv78vu7SLVL0To2rfl2dnU7yaoAGzTH0lItBE69l1MDh3FVsULFp_jejGC7zBTENYvDx8DxnlJI2Oh3SCKoQzehcgI19AfWzvM5yqp7Bl712_30naPowBBbBgAos_oMtc225UYn1GCMqygKdaqkcuoPO5IIbp0ysIycTjrQIgxJCEqENkyJahcVqWLkXwHTJZWGN5rEp0BKWxklhcUtBxljNddKC11NpZBd1uY1s6qYQDzPPwxa89YKakeSj73RBTW1nJ7397Oj428c0TWUmWvC8luSMMoykRhcuasE7L7A7ZsnSdv-zf1r7F-JNeNDpdw-zw4Pep5fwMKzbZwRcrMPieDRxr2Dhsphs-KV6A1TJ7M0
linkToPdf	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LTxRBEK4IJMQLiM8FxU40HkzGdM8M3dMJFwO7gspmIvgIl8n0Y8gGmCXLbhRP_AR-I7_Eqp7Zdb2YGG9zqHlVd3V9Vd31FcBLoZWzZEjeGh6lKpZRaSoEcnJL45IpEDNToLh3qPrfst0u0eRsT2thGn6IWcKNLCOs12TgF66aM3IElaM3IuaZWoClFJ9JzPlJks_2EGSaNS1tNWXi0rglJ6VzPL_v_cMdLZFmf8z5onm8GhxOb_X_PvUerLRAk71tZsYa3PH1fVg-aLfSH8B3kYj92-ubAzpDirGp8fXPq7OTSVkP0J15hnGyG7TZWkbtG859zQY1m1Z_M8rgskCHaRCBj4fnJaOCtNHJkO4gfmhGuwJsHOjTz8qmxql-CJ973aOdvajtwhBZhAIqsvgPtiq15UZlNiCMxFUOQ2qpPAaD3pSCG69MqhMvM46yCIIywhGxjTOXPILFelj7J8B0xaWzRvPUOPSDlfFSWFxQUDFWc5114MV0MIqLhmyjmAYppMMi6LADr8I4zUTK0SkdT1Nbxdf-u-Lwy_H7PM9lITrwuBnImWScSI0BXNKB12G8_vKWIu8efQpX6_8i_ByW891e8XG__2ED7sZN74yIi6ewOB5N_DNYuHSTzTBRfwGMketz
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=131I%E2%80%90Metaiodobenzylguanidine+conditioning+regimen+in+children+with+neuroblastoma+undergoing+stem+cell+transplantation&rft.jtitle=Pediatric+transplantation&rft.au=Atas%2C+Erman&rft.au=Kesik%2C+Vural&rft.au=Kismet%2C+Erol&rft.au=Koseoglu%2C+Vedat&rft.date=2013-06-01&rft.issn=1397-3142&rft.eissn=1399-3046&rft.volume=17&rft.issue=4&rft.spage=407&rft.epage=408&rft_id=info:doi/10.1111%2Fpetr.12087&rft.externalDBID=10.1111%252Fpetr.12087&rft.externalDocID=PETR12087
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1397-3142&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1397-3142&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1397-3142&client=summon